Harvard Bioscience Inc expected to post earnings of 5  cents a share - Earnings Preview

Harvard Bioscience

02/05/2022 19:31

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 4. 
    * The Holliston Massachusetts-based  company is expected to
report
 a 6.6% increase in revenue to $28.77 million from $26.99
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harvard Bioscience
Inc is
for earnings of 5 cents per share. For the same quarter last
year, the company reported earnings of 5 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $10​, above​ its last closing price of $5.22.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.08        0.10       0.08      Missed  -20
 Sep. 30 2021  0.06        0.06       0.06      Met     0
 Jun. 30 2021  0.06        0.06       0.06      Met     -5.3​
 Mar. 31 2021  0.03        0.03       0.05      Beat    50
 ​​Dec.                    0.07       0.08      Beat    23.1
 31 2020                                                
 Sep. 30 2020  0.03        0.04       0.04      Met     14.3​
 Jun. 30 2020  -0.01       -0.01      0.05      Beat    600
 Mar. 31 2020  0.03        0.03       -0.01     Missed  -130
 This summary was machine generated May 2 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated